MeSH term
Frequency | Condition_Probility | Cadherins/biosynthesis/*genetics | 2 | 16.0 |
Colorectal Neoplasms/*genetics/metabolism | 2 | 6.0 |
*DNA Methylation | 24 | 3.0 |
Humans | 40 | 0.0 |
Polymerase Chain Reaction | 9 | 0.0 |
Promoter Regions (Genetics) | 16 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 12 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Tumor Cells, Cultured | 9 | 0.0 |
Adult | 15 | 0.0 |
Aged | 15 | 0.0 |
Aged, 80 and over | 10 | 0.0 |
Female | 22 | 0.0 |
Male | 19 | 0.0 |
Middle Aged | 19 | 0.0 |
*Promoter Regions (Genetics) | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 23 | 0.0 |
Sulfites/pharmacology | 2 | 6.0 |
Risk Factors | 4 | 0.0 |
Prognosis | 9 | 0.0 |
Adolescent | 4 | 0.0 |
Child | 3 | 0.0 |
CpG Islands/*genetics | 2 | 2.0 |
Animals | 3 | 0.0 |
Base Sequence | 4 | 0.0 |
Case-Control Studies | 4 | 0.0 |
Gene Expression Profiling | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Disease-Free Survival | 3 | 0.0 |
Multivariate Analysis | 4 | 0.0 |
Gene Expression Regulation, Neoplastic | 5 | 0.0 |
Gene Silencing | 4 | 1.0 |
Genes, Tumor Suppressor | 10 | 1.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
Down-Regulation | 2 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Transfection | 3 | 0.0 |
Cadherins/*genetics | 5 | 5.0 |
DNA, Neoplasm/*genetics | 3 | 1.0 |
Survival Rate | 4 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Microsatellite Repeats/genetics | 3 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Chromosomes, Human, Pair 16/*genetics | 2 | 2.0 |
DNA Methylation | 3 | 0.0 |
Loss of Heterozygosity/genetics | 2 | 1.0 |
Promoter Regions (Genetics)/*genetics | 3 | 0.0 |
Proportional Hazards Models | 2 | 0.0 |
Genetic Markers | 2 | 0.0 |
Tumor Markers, Biological/genetics | 2 | 2.0 |
Comparative Study | 4 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 4 | 0.0 |
*Genes, Tumor Suppressor | 2 | 0.0 |
Lung Neoplasms/*genetics | 2 | 0.0 |
Neoplasms/*genetics | 2 | 0.0 |
*Acid Anhydride Hydrolases | 2 | 0.0 |
Neoplasm Proteins/*genetics | 5 | 0.0 |
Survival Analysis | 2 | 0.0 |
Cadherins/genetics | 4 | 7.0 |
Lung Neoplasms/etiology/*genetics | 2 | 7.0 |
Protein p16/genetics | 3 | 3.0 |
Receptors, Retinoic Acid/genetics | 3 | 3.0 |
Smoking/*adverse effects | 2 | 0.0 |
*Tumor Suppressor Proteins | 4 | 0.0 |
Adenomatous Polyposis Coli Protein/genetics | 3 | 18.0 |
O(6)-Methylguanine-DNA Methyltransferase/genetics | 3 | 10.0 |
Glutathione Transferase/genetics | 2 | 0.0 |
Isoenzymes/genetics | 2 | 0.0 |
